| Labatec Pharma SA - Ondansetron Labatec 4 mg, comprimés pelliculés | | 65145 | | 01 | | Ondansetron Labatec 4 mg | | comprimés pelliculés | | A04AA01 | | Ondansetron | | 21.11.2014 | | |
| | Composition | | Comprimé pelliculé: ondansetronum 4 mg ut ondansetroni hydrochloridum dihydricum, lactosum monohydricum 84.5 mg, cellulosum microcristallinum, amylum pregelificatum, magnesii stearas, pellicule: hypromellosum, hydroxypropylcellulosum, propylenglycolum, sorbitani oleas, vanillinum, E 104, E 171, E 200 pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose | additional_information |
|---|
| Ondansetron | 4 mg | Comprimé pelliculé |
| | BAG: Active Agent | Dose |
|---|
| Ondansetron | 4 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | color. | | | | color. | | | | conserv. | | | | | | Hypromellosum | | pellicule | | Lactose Monohydrate | 84.5 mg | | | | | | | | | | | Propylenglycol | | | | | | | | Vanilline | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 10 Tablet(s) | 20.56 | 38.85 | B | SL | No |
|
|
